Bradley Foster & Sargent’s Core Laboratories CLB Stock Holding History

Bradley Foster & Sargent’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-6,980	Closed	-$806K	–	347
2017 Q1	$806K	Sell	6,980 -2,160	-24%	-$251K	0.03%	219
2016 Q4	$1.1M	Buy	9,140 +85	+0.9%	+$9.41K	0.05%	195
2016 Q3	$1.02M	Sell	9,055 -1,025	-10%	-$118K	0.04%	191
2016 Q2	$1.25M	Buy	10,080 +6,710	+199%	+$810K	0.06%	167
2016 Q1	$379K	Sell	3,370 -2,175	-39%	-$226K	0.02%	264
2015 Q4	$603K	Buy	5,545 +250	+5%	+$28.6K	0.03%	224
2015 Q3	$528K	Hold	5,295	–	–	0.03%	241
2015 Q2	$604K	Hold	5,295	–	–	0.03%	238
2015 Q1	$553K	Buy	+5,295	New	+$564K	0.03%	248

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bradley Foster & Sargent's CLB Position: Q2 2017 in Review

Bradley Foster & Sargent sold out of Core Laboratories (CLB) in Q2 2017, closing a stake of 6,980 shares — an estimated $806K sold.

Bradley Foster & Sargent first reported a position in CLB in Q1 2015 and held it in 9 quarters. The position peaked at $1.25M in Q2 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

Bradley Foster & Sargent reported no remaining Core Laboratories position as of Q2 2017 after selling out during the quarter.
Bradley Foster & Sargent sold 6,980 Core Laboratories shares in Q2 2017, an estimated $806K.
Bradley Foster & Sargent first reported a position in Core Laboratories in Q1 2015 and held it in 9 quarters.
Bradley Foster & Sargent's Core Laboratories position peaked at $1.25M in Q2 2016.
360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on Bradley Foster & Sargent's 13F filing for Q2 2017, filed 9 Aug 2017.